Sort
326,823 grants matching “clinical trial”
Vascular remodeling in patients with rare genetic disorders
$2,562,680Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Rutgers University CounterACT Center of Excellence
$2,562,572Jeffrey D Laskin · Rutgers Biomedical And Health Sciences · U54 · FY2024 · AR
Development of an Anthrax Vaccine
$2,562,540Sukjoon Park · Emergent Product Development Gaithersbur · N01 · FY2021 · AI
Genetic Modifiers of Cancer Risk
$2,562,510Lisa Mirabello · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
Cancer Center Support Grant
$2,562,428Gerold Bepler · Wayne State University · P30 · FY2020 · CA
Cancer Center Support Grant
$2,562,428Gerold Bepler · Wayne State University · P30 · FY2019 · CA
Cancer Center Support Grant
$2,562,428Gerold Bepler · Wayne State University · P30 · FY2017 · CA
Functional Magnetic Resonance Imaging Of Emotion As Related To Alcoholism
$2,562,361Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2014 · AA
Therapeutic Monoclonal Antibodies to H5N1 Influenza
$2,562,311Richard John Webby · St. Jude Children'S Research Hospital · U01 · FY2009 · AI
SPORE in Brain Cancer
$2,562,260Darell D Bigner · Duke University · P50 · FY2006 · CA
Post DPP Follow Up Study: Data Coordinating Center
$2,562,230George Washington University · U01 · FY2004 · DK
Protection of Ischemic Myocardium
$2,562,122Roberto Bolli · University Of Louisville · P01 · FY2012 · HL
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$2,561,973Pamela J Bjorkman · California Institute Of Technology · P01 · FY2019 · AI
Protection of Ischemic Myocardium
$2,561,937Roberto Bolli · University Of Louisville · P01 · FY2011 · HL
Assessing the role of cerebrovascular brain injury and dysfunction in Alzheimerâs disease pathogenesis in the BEACoN Cohort
$2,561,798Michael A Yassa · University Of California-Irvine · R01 · FY2023 · AG
University of Texas PDX Development and Trial Center
$2,561,686Jack Roth · University Of Tx Md Anderson Can Ctr · U54 · FY2017 · CA
Intervention effects of intensity and delivery style for toddlers with ASD
$2,561,638Sally J Rogers · University Of California At Davis · R01 · FY2016 · MH
Post-Acute Sequelae of SARS-CoV-2 Infection and Subsequent Disease Progression in Individuals with AD/ADRD: Influence of the Social and Environmental Determinants of Health
$2,561,480Hui Hu · Brigham And Women'S Hospital · RF1 · FY2023 · AG
Eastern Cooperative Group Chair's Office
$2,561,235Robert L Comis · Drexel University · U10 · FY2011 · CA
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$2,561,153Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Lymphoma Outcomes SPORE
$2,561,113Christopher R Flowers · University Of Tx Md Anderson Can Ctr · U54 · FY2025 · CA
Molecular epidemiology of acute lymphoblastic leukemia in children with Down syndrome
$2,561,043Karen R Rabin · Baylor College Of Medicine · R01 · FY2020 · CA
Sleeping Beauty Engineered B Cells for Mucopolysaccharidosis
$2,560,312Christiane S Hampe · Immusoft Corporation · R44 · FY2019 · GM
Chemoprevention of Lung Cancer
$2,560,259Marshall W Anderson · University Of Cincinnati · P01 · FY2006 · CA
SIMIAN VACCINE EVALUATION UNITS
$2,560,239Advanced Bioscience Laboratories, Inc. · N01 · FY2000 · AI